Market Blog

Sentiments dictate Xenoport and General Electric

XNPT –  XenoPort, Inc is a biopharmaceutical company, focused on development and commercialization of drugs for the treatment of neurological and other disorders. XNPT – Xenoport, Inc Fundamentals Previously closed at 4.40 Day's high 4.51 Day's low 4.33 P/E ratio NA EPS -1.21   Analysts opinion An Atlanta based private company, Arbor Pharmaceuticals has agreed to acquire XenoPort. Under the terms of agreement, XenoPort stockholders will receive $7.03 per share